ACADIA Pharmaceuticals Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.34B +9.4% €346.25M +27.8% 25.9% +0.037 pp €780.71M +46.6% 58.3% +0.15 pp
    (estimated) €1.22B +8.4% €270.96M +31.4% 22.2% +0.039 pp €532.58M +32.0% 43.5% +0.078 pp
    (estimated) €1.13B +10.6% €206.13M +49.1% 18.3% +0.047 pp €403.57M +67.8% 35.8% +0.12 pp
    (estimated) €1.02B +11.8% €138.21M +67.8% 13.5% +0.045 pp €240.45M +44.3% 23.6% +0.053 pp
    (estimated) €913.34M +11.8% €82.38M -57.4% 9.0% -0.15 pp €166.68M +23.5% 18.2% +0.017 pp
    €816.95M +31.8% €193.15M -469.5% 23.6% +0.32 pp €134.97M +178.8% 16.5% +0.087 pp
    €619.62M +40.4% -€52.27M -71.6% -8.4% +0.33 pp €48.41M -149.8% 7.8% +0.30 pp
    €441.18M +6.8% -€184.22M +28.7% -41.8% -0.071 pp -€97.27M -8.4% -22.0% +0.037 pp
    €412.95M +9.6% -€143.18M -40.4% -34.7% +0.29 pp -€106.22M -3.1% -25.7% +0.034 pp
    €376.80M +30.3% -€240.18M +19.7% -63.7% +0.056 pp -€109.67M -14.3% -29.1% +0.15 pp
    €289.22M +51.5% -€200.66M -4.1% -69.4% +0.40 pp -€127.94M -9.3% -44.2% +0.30 pp
    €190.90M +79.2% -€209.14M -15.3% -109.6% +1.2 pp -€141.01M -23.8% -73.9% +1.0 pp
    €106.53M +620.7% -€246.85M +6.6% -231.7% +13 pp -€185.13M +8.0% -173.8% +9.9 pp
    €14.78M +28,311.5% -€231.48M +65.0% -1,565.9% +2.7K pp -€171.36M +67.9% -1,159.2% +1.9K pp
    €52.03K -49.2% -€140.26M +77.8% -269,578.7% -1.9K pp -€102.06M +80.6% -196,154.1% -1.4K pp
    €102.35K -89.5% -€78.88M +143.7% -77,062.5% -740 pp -€56.51M +112.7% -55,211.7% -520 pp
    €976.63K -76.7% -€32.37M +82.0% -3,314.2% -29 pp -€26.57M +44.0% -2,720.6% -23 pp
    €4.19M +137.4% -€17.78M -8.4% -424.9% +6.8 pp -€18.45M +8.7% -440.8% +5.2 pp
    €1.76M -95.1% -€19.42M -250.4% -1,101.4% -11 pp -€16.97M +85.9% -962.5% -9.4 pp
    €35.94M +558.5% €12.91M -133.5% 35.9% +7.4 pp -€9.13M -21.8% -25.4% +1.9 pp
    €5.46M +302.5% -€38.51M -29.7% -705.5% +33 pp -€11.67M -78.8% -213.9% +39 pp
    €1.36M -79.0% -€54.80M +13.9% -4,040.5% -33 pp -€55.14M +18.6% -4,065.6% -33 pp
    €6.44M -7.1% -€48.10M +25.2% -746.4% -1.9 pp -€46.49M +38.4% -721.5% -2.4 pp
    €6.94M -25.8% -€38.42M +32.0% -553.9% -2.4 pp -€33.60M +104.7% -484.3% -3.1 pp
    €9.35M +138.0% -€29.12M +31.7% -311.6% +2.5 pp -€16.41M -4.3% -175.6% +2.6 pp
    €3.93M -37.6% -€22.11M +83.9% -562.9% -3.7 pp -€17.15M +150.1% -436.7% -3.3 pp
    €6.29M +17.6% -€12.02M +9.5% -191.0% +0.14 pp -€6.86M -9.3% -109.0% +0.32 pp
    €5.35M +45.5% -€10.98M +26.2% -205.1% +0.31 pp -€7.56M -∞% -141.2% -1.4 pp
    €3.68M -€8.69M -236.4% €0.00 0.0%

    Notifications